Medicinal Cannabis Matters: Friday Roundup - 28 August 2026

Understanding Medical Cannabis Vaporisation

Vaporisation is one of the most common ways medicinal cannabis flower is administered, but there is often confusion around how it works and why temperature and device choice matter.

A recent article explores the practical side of medical cannabis vaporisation, explaining why prescribed cannabis should not be smoked and how vaporisation heats the flower below the point of combustion. This allows the active compounds to be released without producing the same combustion by-products associated with smoking.

Temperature also plays an important role. Different compounds in cannabis are released at different temperatures, meaning the temperature selected on a vaporiser can influence the vapour produced and the compounds being released. There is no single temperature that is right for every patient or product, which is why patients should always follow the instructions provided as part of their treatment plan.

A Positive THC Test Does Not Automatically Mean Impairment

As more people are prescribed medicinal cannabis, questions around THC testing and the workplace are becoming increasingly important.

A recent article from Cannabis Health News explores the distinction between detecting THC in someone's system and determining whether they are actually impaired.

A drug test can detect the presence of THC, but that does not necessarily tell an employer whether someone is impaired at the time the test is taken. THC can remain detectable in the body for days or weeks after use, meaning a positive result alone cannot establish how a person is functioning at that particular moment.

This distinction is particularly important for people with a legal prescription. The article highlights how workplace drug policies can sometimes treat prescribed medicinal cannabis in the same way as illicit drug use, despite the two being very different circumstances.

That does not mean safety considerations should be overlooked. For roles where impairment could present a genuine risk, employers still have a responsibility to assess the individual and the specific requirements of their role. The article suggests that this should focus on the person's actual functioning and the risks associated with their job, rather than simply assuming that a positive test means they are impaired.

As medicinal cannabis becomes more widely prescribed, better understanding of the difference between prescription and impairment will be increasingly important for both employers and patients.

What Do Patients Need to Know About Disclosure at Work?

The conversation around medicinal cannabis and employment continues with a second article from Cannabis Health News, this time focusing on disclosure, privacy and employee rights.

There is no general legal requirement for every UK employee to tell their employer that they have a medicinal cannabis prescription. However, there may be circumstances where disclosure is relevant, particularly where a workplace policy requires it or where treatment could have a material impact on safety.

For patients, this can be a difficult conversation to navigate. Concerns about stigma, drug testing or how colleagues and managers might respond can make people understandably reluctant to disclose their prescription.

The article highlights the importance of sharing information that is necessary and proportionate. An employer may need to understand practical considerations around fitness to work, safety or reasonable adjustments, but that does not automatically mean they need access to an employee's entire medical history. An occupational health assessment may be a more appropriate way of addressing these questions.

Clearer workplace policies could help make these conversations easier. Rather than waiting for a positive drug test or workplace incident to raise the issue, employers and employees can benefit from having an informed and constructive approach to prescribed medicines.

As the number of medicinal cannabis patients in the UK grows, improving awareness in workplaces will be an important part of reducing stigma and ensuring patients are treated fairly.

At Medicann, we believe patients should have access to clear, evidence-led information alongside safe, clinically supervised treatment.

If you're considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in just two minutes.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.